The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: A new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100)

Mutagenesis

Volumn 22, Issue 1, 2007, Pages 75-81

  Duarte, Maria Paula ^a,b   Palma, Bernardo Brito ^a   Gilep, Andrei A ^c   Laires, António ^a,b   Oliveira, José Santos ^b   Usanov, Sergey A ^c   Rueff, José ^a   Kranendonk, Michel ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOANTHRACENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CYTOCHROME B5; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE;

ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MEMBRANE; MUTAGEN TESTING; MUTAGENESIS; MUTAGENICITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; BIOTRANSFORMATION; CLONING, MOLECULAR; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; CYTOCHROMES B5; ENZYME ACTIVATION; GENETIC VECTORS; HUMANS; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; MUTAGENICITY TESTS; MUTAGENS; PLASMIDS; RATS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

BACTERIA (MICROORGANISMS);

EID: 33846094609     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gel054     Document Type: Article

References (14)

1. Duarte,M.P., Palma,B.B., Gilep,A.A., Laires,A., Oliveira,J.S., Usanov,S.A., Rueff,J and Kranendonk,M. (2005) The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6, and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation. Mutagenesis, 20, 93-100.
2. Friedberg,T., Pritchard,M.P., Bandera,M., Hanlon,S.P., Yao,D., Mclaughlin,L.A., Ding,S., Burchell,B. and Wolf,C.R. (1999) Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intra-laboratory comparison. Drug Metab. Rev., 31, 523-544.
3. Parikh,A., Gillam,E.M. and Guengerich,F.P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol., 15, 784-788.
4. Kranendonk,M., Laires,A., Rueff,J., Estabrook,R.W. and Vermeulen,N.P.E. (2000) Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations. Crit. Rev. Toxicol., 30, 287-306.
5. Yamazaki,H., Nakamura,M. and Komatsu,T. et al. (2002) Roles of NADPH-P450 reductase and apo-and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Prot. Expres. Purif., 24, 329-337.
6. Holmans,P.L., Shet,M.S., Martin-Wixtrom,C.A., Fisher,C.W. and Estabrook,R.W. (1994) The high-level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function. Arch. Biochem. Biophys., 2, 554-565.
7. Shimada,T., Mernaugh,R.L. and Guengerich,F.P. (2005) Interactions of mammalian cytochrome P450 NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes. Arch. Biochem. Biophys., 435, 207-216.
8. Clarke,T.A., Im,S.C., Bidwai,A. and Waskell,L. (2004) The role of the length and sequence of the linker domain of cytochrome b5 in stimulating cytochrome P450 2B4 catalysis. J. Biol. Chem., 279, 36809-36818.
9. Naffin-Olivos,J.L. and Auchus,R.J. (2006) Human cytochrome b5 requiresresidues E48 and E49 to stimulate the 17,20-lyase activity of cytochromeP450c17. Biochemistry, 45, 755-762.
10. Gao,Q., Doneanu,C.E., Shaffer,S.A., Adman,E.T., Goodlett,D.R. and Nelson,S.D. (2006) Identification of the interactions between cytochrome P450 2E1 and cytochrome b5 by mass spectrometry and site-directed mutagenesis. J. Biol. Chem., 281, 20404-20417.
11. Schenkman,J.B. and Jansson,I. (1999) Interactions between cytochrome P450 and cytochrome b5. Drug Metab. Rev., 31, 351-364.
12. Yang,W.H. and Hammes,S.R. (2005) Xenopus leavis CYP17 regulates androgen biosynthesis independent of the cofactor cytochrome b5. J. Biol. Chem., 280, 10196-10201.
13. Venkatakrishnan,K., Von Moltke,L.L., Court,J.S., Harmatz,J.S., Crespi,C.L. and Greenblatt,D.J. (2000) Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between approaches. Drug Metab. Dispos., 28, 1493-1504.
14. Paine,M.F., Khalighi,M., Fisher,J.M., Shen,D.D., Kunze,K.L., Marsh,C.L., Perkins,J.D. and Thummel,K.E. (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A4-dependent metabolism. J. Pharmacol. Exp. Ther., 283, 1552-1562.